Mini-Reviews in Medicinal Chemistry
Title:Editorial (Thematic Issue: Targeted Therapies)
Volume: 17 Issue: 3
Author(s): Alan Talevi and Guillermo R. Castro
Affiliation:
Export Options
About this article
Cite this article as:
Talevi Alan and Castro R. Guillermo, Editorial (Thematic Issue: Targeted Therapies), Mini-Reviews in Medicinal Chemistry 2017; 17 (3) . https://dx.doi.org/10.2174/138955751703170109160702
DOI https://dx.doi.org/10.2174/138955751703170109160702 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
19
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Molecular Docking and 3D-QSAR Studies on Quinolone-based HDAC Inhibitors
Letters in Drug Design & Discovery Clinical, Immunological and Therapeutic Aspects of Autoimmune Encephalitis
Recent Patents on CNS Drug Discovery (Discontinued) In the Rush for Green Gold: Can Green Tea Delay Age-Progressive Brain Neurodegeneration?
Recent Patents on CNS Drug Discovery (Discontinued) Early Diagnosis of Multiple Sclerosis Based on Optical and Electrochemical Biosensors: Comprehensive Perspective
Current Analytical Chemistry Antisense Oligodeoxynucleotide Therapy for Prostate Cancer Targeting Antiapoptotic Genes Involved in the Mechanism Mediating Progression to Androgen Independence
Current Signal Transduction Therapy Future Prospects for Old Chemotherapeutic Drugs in the Target-Specific Era; Pharmaceutics, Combinations, Co-Drugs and Prodrugs with Melphalan as an Example
Letters in Drug Design & Discovery Arene ruthenium(II) Complexes: The Promising Chemotherapeutic Agent in Inhibiting the Proliferation, Migration and Invasion
Mini-Reviews in Medicinal Chemistry Radiolabelled Tracers and Anticancer Drugs for Assessment of Therapeutic Efficacy Using PET
Current Pharmaceutical Design Drug-Metabolizing Enzymes Mechanisms and Functions
Current Drug Metabolism The Role of Wnt/Beta-Catenin Signaling in Renal Carcinogenesis: Lessons from Cadmium Toxicity Studies
Current Molecular Medicine Targeting Aurora Kinases in Cancer Treatment
Current Drug Targets Application of MALDI-TOF Mass Spectrometry in Screening and Diagnostic Research
Current Pharmaceutical Design Synthesis and Antimicrobial Evaluation of Amphipathic Peptide Models
Letters in Drug Design & Discovery Semi-Synthetic Derivatives of Heliomycin with an Antiproliferative Potency
Recent Patents on Anti-Cancer Drug Discovery Small Molecule De-Repression of BAX and BAK Oligomerization as a Strategy for Treating Cancer
Letters in Drug Design & Discovery Hypocholesterolemia
Current Vascular Pharmacology Oncostatin M: Potential Implications for Malignancy and Metabolism
Current Pharmaceutical Design Chemoprevention Strategies for High Risk Women
Current Women`s Health Reviews Editorial [Peptides and Proteins in Cancer Therapy]
Protein & Peptide Letters Role of Glucocorticoids in Breast Cancer
Current Pharmaceutical Design